A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

Ethicon Launches ECHELON ENDOPATH Staple Line Reinforcement: Reduces Complications Associated with Bariatric, Thoracic and General Surgical Procedures

Offers Significant Improvements Over Existing Buttressing Solutions

Ethicon, part of Johnson & Johnson Medical Devices Companies, announced today the launch of ECHELON ENDOPATH Staple Line Reinforcement (SLR), a novel buttressing device designed to further strengthen staple lines and reduce potential complications during bariatric, thoracic and general surgical procedures. This is the company’s first buttress solution designed for use with its own industry-leading ECHELON FLEX™ Powered Staplers with GST reloads, which have been associated with a lower rate of air leaks and bleeding complications.[i],[ii] 

Ethicon developed the ECHELON ENDOPATH SLR to help surgeons who want even more strength around the staple line and to overcome issues with current buttressing options which can be difficult to load, result in inconsistent staple line coverage and may loosen with typical maneuvering during stapling procedures.

“The ECHELON ENDOPATH SLR takes a different approach to buttressing that offers significant improvements in ease of use, functionality and OR efficiency.[iii]  For those who buttress, I expect this will become their preferred solution,” said Neil Floch MD, FACS, Director of Minimally Invasive and Bariatric Surgery, Norwalk Hospital.***

Designed for ease of use, the ECHELON ENDOPATH SLR delivers a seamless buttress experience from start to finish.[iv] The device’s simple click-and-go applicator and proprietary buttress attachment material are designed for precise control, consistent and quicker loading, and a more secure attachment for uninterrupted tissue manipulation and release.[v] The new device prevents the slipping, twisting, sliding or bunching that can occur with other buttress options and provides greater stability when manipulating tissue.[vi]

The ECHELON ENDOPATH SLR also provides exceptional coverage after tissue manipulation. Studies show 100% of its applications covered all staples with buttress[vii] compared to 28%[viii] for GORE® SEAMGUARD® Bioabsorbable SLR and 0% for Medtronic’s Endo GIA™ Reinforced Reload with Tri-Staple Technology.[ix] The Ethicon device also showed higher average reinforcement,[x] and takes fewer steps and less time to load than the GORE product.[xi]

“The launch of the ECHELON ENDOPATH SLR marks a new milestone in Ethicon’s continuing commitment to provide a better way to staple, and now a better way to buttress, when needed in minimally-invasive surgical procedures,” said Tom O’Brien, Worldwide President Endomechanical, Ethicon, Inc.  “At Ethicon, we continually look for ways to optimize usability for surgeons and improve patient outcomes.”


[i] Miller DL, Roy S, Kassis ES. et al. Impact of powered and tissue-specific endoscopic stapling technology on clinical and economic outcomes of video-assisted thoracic surgery lobectomy procedures: a retrospective, observational study. Advances in Therapy (2018). https://doi.org/10.1007/s12325-018-0679-z.

[ii] Klassen C, Eckert CE, Wong J. et al. Ex Vivo Modeling of Perioperative Air Leaks in Porcine Lungs. IEEE Transactions on Biomedical Engineering (2018). https://ieeexplore.ieee.org/document/8325303/

[iii] Wong JB, Henninger DD, Clymer JW. et al. A Novel, Easy-to-Use Staple Line Reinforcement for Surgical Staplers. Medical Devices: Evidence and Research. 2020:12 23-29.

[iv] Based on coverage after manipulation assessment on porcine tissue.

[v] Based on coverage after manipulation assessment on porcine tissue.

[vi] Based on coverage after manipulation assessment on porcine tissue.

[vii] In a tissue test ECHELON ENDOPATH™ Reinforcement covered all staple legs in (40/40) applications compared to GORE™ SEAMGUARD™ (11/40), p<0.05.

[viii]  In a tissue test ECHELON ENDOPATH™ Reinforcement covered all staple legs in (40/40) applications compared to GORE™ SEAMGUARD™ (11/40), p<0.05.

[ix] In a tissue test ECHELON ENDOPATH™ Staple Line Reinforcement fully covered staple legs in (15/15) applications compared to Endo GIA™ Reinforced Reload with Tri-Staple™ Technology (0/15), p<0.05.

[x] Reinforcement measured via in vitro staple pull-through force at T=0, T=7, and T=14 days resulting in mean values: ECHELON ENDOPATH™ Reinforcement (22.02N, 10.65N, 2.93N) vs. GORE® SEAMGUARD® Reinforcement (7.33N, 5.52N, 2.35N), p<0.05. 109221-190311

[xi] Ricketts C, Pollack E. Evaluation of setup by nurses of a novel click and go staple line reinforcement system. Glob Surg. 2020;6. doi:10.15761/GOS.1000215.

SourceEthicon
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy